Testosterone-induced activation of fibrinolysis in carcinoma of the prostate.
D000614:Aminocaproates / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy; D004054:Diethylstilbestrol / Q000627:therapeutic use; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D010759:Phosphorus Isotopes / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D013739:Testosterone / Q000009:adverse effects*
D000614:Aminocaproates; D010759:Phosphorus Isotopes; D013739:Testosterone; D004054:Diethylstilbestrol